by ASTCT Advocacy Update
Mark your calendars for ASTCT's Government Relations Spotlight Session titled "Inside the Administration - Insight into the Federal Government and How We Can Make a Lasting Impact"...
by Alex Kadhim
Researchers at SickKids Hospital and McMaster University have developed a novel chimeric antigen receptor (CAR) T-cell therapy targeting ROBO1, a protein involved in axonal guidance, for the...
by Blood
Based on results from the OUTREACH study, outpatient monitoring appears to be both safe and effective for patients with relapsed/refractory large B-cell lymphoma who undergo lisocabtagene...
FOCIS 2025 will be the 25th Annual Meeting of the Federation of Clinical Immunology Societies. The Scientific Program Committee will develop the FOCIS 2025 Scientific Program for the target...
by Dr. Corey Cutler, MD, MPH
In the November President's Message, Dr. Corey Cutler, MD, MPH, brings a look back at an eventful season packed with progress and collaboration.
by Nature Medicine
Researchers report that while autologous chimeric antigen receptor (CAR) T-cell manufacturing is possible in the setting of acute myeloid leukemia (AML), myeloid-supporting cytokines released...